1. Home
  2. ELEV vs BWEN Comparison

ELEV vs BWEN Comparison

Compare ELEV & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELEV
  • BWEN
  • Stock Information
  • Founded
  • ELEV 2019
  • BWEN N/A
  • Country
  • ELEV United States
  • BWEN United States
  • Employees
  • ELEV N/A
  • BWEN N/A
  • Industry
  • ELEV Biotechnology: Pharmaceutical Preparations
  • BWEN Industrial Machinery/Components
  • Sector
  • ELEV Health Care
  • BWEN Industrials
  • Exchange
  • ELEV Nasdaq
  • BWEN Nasdaq
  • Market Cap
  • ELEV 37.6M
  • BWEN 39.6M
  • IPO Year
  • ELEV 2021
  • BWEN N/A
  • Fundamental
  • Price
  • ELEV $0.66
  • BWEN $1.85
  • Analyst Decision
  • ELEV Buy
  • BWEN Strong Buy
  • Analyst Count
  • ELEV 6
  • BWEN 3
  • Target Price
  • ELEV $7.20
  • BWEN $5.17
  • AVG Volume (30 Days)
  • ELEV 4.3M
  • BWEN 199.8K
  • Earning Date
  • ELEV 03-05-2025
  • BWEN 03-04-2025
  • Dividend Yield
  • ELEV N/A
  • BWEN N/A
  • EPS Growth
  • ELEV N/A
  • BWEN N/A
  • EPS
  • ELEV N/A
  • BWEN 0.14
  • Revenue
  • ELEV N/A
  • BWEN $156,169,000.00
  • Revenue This Year
  • ELEV N/A
  • BWEN N/A
  • Revenue Next Year
  • ELEV N/A
  • BWEN $25.42
  • P/E Ratio
  • ELEV N/A
  • BWEN $13.13
  • Revenue Growth
  • ELEV N/A
  • BWEN N/A
  • 52 Week Low
  • ELEV $0.50
  • BWEN $1.52
  • 52 Week High
  • ELEV $5.83
  • BWEN $4.65
  • Technical
  • Relative Strength Index (RSI)
  • ELEV 48.99
  • BWEN 47.70
  • Support Level
  • ELEV $0.65
  • BWEN $1.76
  • Resistance Level
  • ELEV $0.98
  • BWEN $2.12
  • Average True Range (ATR)
  • ELEV 0.12
  • BWEN 0.16
  • MACD
  • ELEV -0.01
  • BWEN -0.01
  • Stochastic Oscillator
  • ELEV 18.38
  • BWEN 15.25

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through three operating segments namely Heavy Fabrications, Gearing and Industrial Solutions.

Share on Social Networks: